Quoin Pharmaceuticals, Ltd.
QNRXNext catalyst
QRX003, Lotion
Netherton Syndrome
Get an email about QNRX's next catalysts
Track Quoin Pharmaceuticals (QNRX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (Phase 3 readout).See the timeline
2 upcoming, 2 past
QRX003, Lotion Phase 3 Est. Readout
Estimated primary completion for QRX003, Lotion trial (NCT06953466) in Netherton Syndrome. Topline data typically follows completion by weeks to months.
SourceQRX003 Phase 3 Est. Readout
Estimated primary completion for QRX003 trial (NCT07538583) in Netherton Syndrome. Topline data typically follows completion by weeks to months.
SourceMarket Overview
Stock performance and key metrics
QRX003, Lotion
Netherton Syndrome
QRX003-2% Lotion
Netherton Syndrome
QRX003
Netherton Syndrome
QRX003-4% Lotion QAM
Netherton Syndrome
QRX003-4% Lotion BID
Netherton Syndrome
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
QRX003, Lotion | Phase 3 | Netherton Syndrome | - | - |
QRX003-2% Lotion | Phase 3 | Netherton Syndrome | - | - |
QRX003 | Phase 3 | Netherton Syndrome | - | - |
QRX003-4% Lotion QAM | Phase 3 | Netherton Syndrome | - | - |
QRX003-4% Lotion BID | Phase 3 | Netherton Syndrome | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Quoin Pharmaceuticals, Ltd.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in Quoin Pharmaceuticals, Ltd.'s (QNRX) pipeline across Phase 3. Its lead program is QRX003 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Quoin Pharmaceuticals, Ltd.'s next FDA catalyst?→
Quoin Pharmaceuticals, Ltd.'s (QNRX) next tracked catalyst is a Phase 3 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track QNRX biotech catalysts?→
Add QNRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Quoin Pharmaceuticals, Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.